Difference between revisions of "Team:Toulouse-INSA-UPS/Results"

 
(38 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 
<!--THIS COMES BEFORE THE CONTENT-->
 
<!--THIS COMES BEFORE THE CONTENT-->
{{Template:Toulouse-INSA-UPS/SCROLLSPY}} <html>
+
{{Template:Toulouse-INSA-UPS/SCROLLSPY}}  
 +
<html>
 
   <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:Toulouse-INSA-UPS/BS-CSS&action=raw&ctype=text/css"/>
 
   <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:Toulouse-INSA-UPS/BS-CSS&action=raw&ctype=text/css"/>
 
   <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:Toulouse-INSA-UPS/PERSO-CSS&action=raw&ctype=text/css"/>
 
   <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:Toulouse-INSA-UPS/PERSO-CSS&action=raw&ctype=text/css"/>
  
 
     <!--Banner-->
 
     <!--Banner-->
  <div class="container-fluid parallax" style="background-image: url('https://static.igem.org/mediawiki/2018/c/cc/T--Toulouse-INSA-UPS--Safety--Brice--Banner.jpg'); background-size: cover; background-position-y: top;" id="BANNER"></div>
+
<div class="container-fluid parallax" style="background-image: url('https://static.igem.org/mediawiki/2018/a/a4/T--Toulouse-INSA-UPS--project--Brice--Banner.jpg'); background-size: cover; background-position-y: center; " id="BANNER"></div>
  
 
</html> {{Template:Toulouse-INSA-UPS/MENU}} <html>
 
</html> {{Template:Toulouse-INSA-UPS/MENU}} <html>
 
+
 
     </div>
 
     </div>
 
</html> {{Template:Toulouse-INSA-UPS/CONTENT-BEGINNING}} <html>
 
</html> {{Template:Toulouse-INSA-UPS/CONTENT-BEGINNING}} <html>
 +
 
<!--CONTENT COMES HERE-->
 
<!--CONTENT COMES HERE-->
  
  
        <div class="column full_size">
+
<!--Here goes the content-->
  
          <h1>SAFETY</h1>
+
<!--TITLE+INTRO-->
        <hr/>
+
<h1 class="heavy">RESULTS</h1>
 +
<hr/>
 +
<p>
 +
The whole Cerberus project is based on the construction and validation of a proteic platform to link very different molecules together. This platform is composed of three heads. The first head is a CBM3a domain which specifically binds cellulose. The second head is a streptavidin domain with a strong affinity to biotinylated compounds. The third head is based on the presence of an unnatural amino acid to covalently link any molecule with an alkyne moiety.
 +
</p>
 +
<p>To validate the Cerberus platform, we worked head by head, starting from the CBM3a validation, then the streptavidin domain assessment and finally the demonstration of the unnatural amino acid capacity to covalently bound alkynilated molecules. Thus, our first construction has only one head and was named Sirius, after the brightest star of the northern hemisphere, alpha canis majoris. The second construction presents both the CBM3a and streptavidin heads and was nicknamed Orthos, a two-headed mythological dog. The final construction is Cerberus with its three heads.</p>
  
        <p>There is a lot of dangers in a laboratory. So, everything cannot be done and there are rules to respect to protect the environment and ourselves. Due to an atmosphere of mistrust concerning GMOs in France, it is also very important to us to appease the opinion with a strict safety policy.</p>
+
<div id="HP_Tab_Group">
        <p>First, we will present here how the safety department in INSA is organized: what kind of structure received us, what is the French legislation concerning risks and how we have been formed. Then, we will detail what kind of risks we could met during the lab work and how we should avoid them with good laboratory habits. Finely, we will explain how we constructed our project to minimize the health and safety issues.</p>
+
<!--SUB MENU OF results-->
 +
<ul class="nav nav-pills d-flex flex-row flex-wrap" role="tablist">
 +
<li class="nav-item">
 +
<a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1 active" data-toggle="pill" href="#Results_Part1" role="tab" style="color:white !important;">Sirius: CBM3a</a>
 +
</li>
 +
<li class="nav-item">
 +
<a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1" data-toggle="pill" href="#Results_Part2" role="tab" style="color:white !important;">Orthos: Streptavidin</a>
 +
</li>
 +
<li class="nav-item">
 +
<a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1" data-toggle="pill" href="#Results_Part3" role="tab" style="color:white !important;">Cerberus: AzF</a>
 +
</li>
 +
<li class="nav-item">
 +
<a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1" data-toggle="pill" href="#Results_Part4" role="tab" style="color:white !important;">Bacterial Cellulose</a>
 +
</li>
 +
</ul>
  
        <div id="Description_tab">
+
<!--Common Member banner-->
                <!--SUB MENU OF Notebook-->
+
<div class="hr_img">
                <ul class="nav nav-pills d-flex flex-row flex-wrap flex-lg-nowrap justify-content-around justify-content-lg-start" role="tablist">
+
<img class="hr_img filter-gray-90" src="https://static.igem.org/mediawiki/2018/1/11/T--Toulouse-INSA-UPS--bannersmall--Brice--Banner.jpg" alt="A banner" />
                    <li class="nav-item">
+
</div>
                        <a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1 active" data-toggle="pill" href="#Safe_Part1" role="tab">Safety Department</a>
+
                    </li>
+
<div class="tab-content">
                    <li class="nav-item">
+
 
                        <a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1" data-toggle="pill" href="#Safe_Part2" role="tab">Knowing the Risks</a>
+
<!--PART 1 : Sirius-->
                     </li>
+
<div class="tab-pane fade show active" id="Results_Part1" role="tabpanel">
                     <li class="nav-item">
+
<h2 id="Sirius" class="heavy">Sirius: CBM3a</h2>
                        <a class="nav-link btn btn-secondary rounded-top corner-bottom mr-1" data-toggle="pill" href="#Safe_Part3" role="tab">Project Construction</a>
+
<hr/>
                     </li>
+
              </ul>
+
<h3 id="Background_Sirius" class="heavy">Background</h3>
           
+
                    <p>
                <!--Common HR banner-->
+
Sirius is a fusion protein between CBM3a and mRFP1. This design, which consists of fusing CBM3a to a fluorescent moiety, allowed us to investigate the binding capability of the CBM3a domain to cellulose through the four aromatic amino acids of its binding domain. mRFP1 was chosen since it is both a coloured and fluorescent protein.
                <div class="hr_img">
+
</p>
                     <img class="hr_img filter-gray" src="https://static.igem.org/mediawiki/2018/1/11/T--Toulouse-INSA-UPS--bannersmall--Brice--Banner.jpg" alt=""/>
+
                    <h3 id="Key_Achievements_Sirius" class="heavy">Key Achievements</h3>
                </div>
+
                      
               
+
                    <p>
                <div class="tab-content">
+
                    <ul>
                     <!--PART 1 -->
+
                    <li> <p><i>Cloning of the part encoding Sirius</i></p></li>
                     <div class="tab-pane fade show active" id="Safe_Part1" role="tabpanel">
+
                     <li> <p><i>Overexpression and purification of Sirius</i></p></li>
                            <h2 id="SD" class="heavy">INSA Safety Department</h2><hr/>
+
                     <li> <p><i>Fixation of Sirius to cellulose</i></p></li>
<div style="text-align:center">
+
                    </ul>
                            <figure class="figure" style="text-align:center;">
+
                    </p>
                                <img style="width : 70%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/d/d3/T--Toulouse-INSA-UPS--BET-room.jpg" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
+
                    <h3 id="Materials_Methods_Sirius" class="heavy">Materials and Methods</h3>
                                <figcaption class="figure-caption"><strong>Figure 1:</strong> Ethidium Bromide Handling Room.</p>
+
                     <p>
                                    </figcaption>
+
The fused CBM3a and mRFP1 sequences were cloned into the pET28 expression vector in fusion with a histidine tag (Figure 1).
                                    </figure>
+
</p>
</div>
+
<figure class="figure"  style="text-align:center;">
                          <h3 id="SD-org" class="heavy">Organization of the INSA Safety Department</h3>
+
<img style="width : 70%; height: auto;" src="https://static.igem.org/mediawiki/2018/4/4f/T--Toulouse-INSA-UPS--Results--Youn--constructSirius.png" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
           
+
<figcaption class="figure-caption"><strong>Figure 1:</strong> <i>Scheme of the Sirius construction</i></figcaption>
                            <p>We have been received by the LISBP. The head of the laboratory where we worked is Carole Jouve and the organization of the safety department is described in the figure 1 below. We are very grateful for the welcoming of our colleagues and the time they spend to form us.</p>
+
</figure>
<div style="text-align:center">
+
<p>The resulting construct was transformed into <em>E. coli</em> strain and expression of the recombinant protein was induced using IPTG. The His-tagged protein was then purified on IMAC resin charged with cobalt and used in cellulose pull down assays. For the experimental details, see <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Experiments">Experiments page</a>.</p>
<figure class="figure"  style="text-align:center;">
+
                     <h3 id="Results_Discussion_Sirius" class="heavy">Results and Discussion</h3>
                                <img style="width : 80%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/b/b1/T--Toulouse-INSA-UPS--All--Angeline--Safety1.png" class="figure-img img-fluid rounded" alt="organization chart">
+
                     <h4 id="Production_purification_Sirius" class="heavy">Production and purification of Sirius</h4>
                                <figcaption class="figure-caption"><i><strong>Figure 2:</strong> Organization chart of the INSA safety department.</i>
+
<p>Interestingly, <i>E. coli</i> turned a deep pink shade after induction, indicating a strong production of Sirius (Figure 2).</p>
                                    </figcaption>
+
<div style="text-align:center">
                                    </figure>
+
<figure class="figure" id="figure" style="text-align:center;">
</div>
+
<img style="width : 40%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/9/96/T--Toulouse-INSA-UPS--Results--Youn--fig2sirius.jpg" class="figure-img img-fluid rounded" alt="SDS Page">
           
+
<figcaption id="figcaption" class="figure-caption"><strong>Figure 2:</strong><i> E. coli expressing Sirius </i></figcaption>
                          <h3 id="SD-law" class="heavy">Legislation and French labor Law</h3>
+
</figure>
           
+
</div>
                            <p>We are working in a french engineering school (INSA Toulouse), thus we have to respect the french national regulations about working conditions and manipulation of GMOs.</p>
+
<div style="text-align:center">
                            <p>As we work with microorganisms, we are concerned by the regulation on workers protection against risks resulting from their exposure to pathogenic biological agents (Decree No. 94-352 of 4 May 1994). It also includes human endoparasites which may cause infections, allergies or toxicity. This Decree is the French transposition of the Directive 90/679 / EEC and is also transcribed in the Labour Code (Articles L4421-1 R4421-1 to R4427-5). This Decree of the 16th July 2007 describes the technical preventive measures that must be followed in research laboratories, where workers are likely to be exposed to biological pathogens. We must obey to the rules of health, safety, and preventive medicine applied in public services in France (Decree No. 82-453). This decree refers to the Labour Code, Public Health Code and Environmental Code.</p>
+
<figure class="figure" id="figure" style="text-align:center;">
           
+
<img style="width : 50%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/c/c3/T--Toulouse-INSA-UPS--Collaborations--GB--SDSPAGE_Analysis.jpg" class="figure-img img-fluid rounded" alt="SDS Page">
                          <h3 id="SD-form" class="heavy">Formation received</h3>
+
<figcaption id="figcaption" class="figure-caption"><strong>Figure 3:</strong> <i>SDS-PAGE analysis of Sirius purification. (CFE: cell free extract, FT: flow through, W: washes, E1/40: elution with 40mM imidazole, E1/100: elution with 100 mM imidazole, E2/100: elution with 100 mM imidazole, E1/300: elution with 300 mM imidazole, MW: molecular weight ladder.) </i></figcaption>
                            <p>To follow the legislation, we have been formed by Nathalie Doubrovine, the supervisor of the safety department of the LISBP. Her goal is to ensure both the well-being of the employees and the respect of safety rules and risk prevention. During the summer, we received different formations:
+
</figure>
                              <ul>
+
</div>
                                <li><p>General information: two formations have been done, one during a meeting with Nathalie Doubrovine and the other with the software NEO. General information has been presented about the chemical, biological and fire risks. We also learned the prevention of those risks and the reaction to have when one of those risks occurs. At the end of the formation, a little test was done to see if everyone understood everything. Also, before using any new device, a quick formation is done.</p></li>
+
<p>
                                <li><p>Autoclave formation: our team has attended an autoclave training, which showed us the explosive and implosive dangers of the dispositive and the security measures to take to protect ourselves. A lab coat, heat resistant gloves and glasses were required for the manipulation of the autoclave. The standard protocols of loading and unloading it were also demonstrated.</p></li>
+
As shown in Figure 3, we successfully purified the Sirius protein. Indeed, induction with IPTG produced a large amount of a protein at the expected size for Sirius (52 kDa, lane CFE). This protein was then found to be predominant in elution samples (E1/40 and E1/100). We estimated the degree of purity of full-length Sirius at about 72%. In addition to the full-length protein, we observed several extra bands that likely correspond to proteolysis products.
                                 
+
</p>
                                <li><p>Ethidium bromide room: because of the oncogenic risk of the ethidium bromide, we have a specific room where we must work with this solution. Nothing can get outside the room when it comes inside and everyone in the room must wear protection gloves, a lab coat and protection goggles. UV are also used in this room and protection mask must be wore during its use.</p></li>
+
                              </ul>
+
                            </p>
+
                   
           
+
                    <h4 id="Validation_Sirius" class="heavy">Validation</h4>
                               
+
                    <p>
                     </div>
+
Once produced in <em<E. coli</Em>, Sirius binding to cellulose was tested using pull down assays. 70 &mu;M of Sirius protein or mRFP1 (without CBM3a) or buffer were incubated with cellulose. After five washes with Tris-HCl buffer, cellulose pellets were recovered and the associated fluorescence was measured.</p>
 +
                   
 +
                    <p>
 +
When mRFP1 was added alone to cellulose, its associated colour mostly remained in the supernatant (Figure 4). When Sirius was associated with cellulose, the pinkish colour was clearly associated to the cellulose pellet. Quantification of the cellulose-associated fluorescence backed up these observations (Figure 5): control experiments showed that only background levels of fluorescence are retained in the cellulose pellet incubated with mRFP1 alone. These experiments have been performed in triplicate and statistical analyses indicate that the high level of fluorescence obtained with Sirius is definitively significant. These results clearly show that the CBM3a domain of Sirius interacts with cellulose, and thus mediates binding of mRFP1 protein to cellulose.  
 +
                    </p>
 +
<div style="text-align:center">
 +
<figure id="figure2" class="figure"  style="text-align:center;">
 +
  <img style="width : 45%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/6/61/T--Toulouse-INSA-UPS--Results--Youn--CPDSirius.png" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
 +
<figcaption id="figcaption2" class="figure-caption"><strong>Figure 4:</strong> <i>Picture of cellulose pull-down assay with mRFP1 alone (left tube) or with the Sirius construction (right tube)</i></figcaption>
 +
</figure>
 +
  </div>
 +
<div style="text-align:center">
 +
  <figure id="figure2" class="figure"  style="text-align:center;">
 +
    <img style="width : 60%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/b/bb/T--Toulouse-INSA-UPS--Collaborations--GB--FluoRetained.jpg" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
 +
      <figcaption id="figcaption2" class="figure-caption"><strong>Figure 5:</strong> <i>Binding of Sirius to cellulose. Fluorescence retained in the cellulose pellet after pull down (triplicate test)</i></figcaption>
 +
  </figure>
 +
</div>
 +
</div>
 +
 +
<!--PART 2 : Orthos-->
 +
<div class="tab-pane fade" id="Results_Part2"  role="tabpanel">
 +
<h2 id="Orthos" class="heavy">Orthos: Streptavidin and biotinylated compounds</h2>
 +
<hr/>
 +
 +
<h3 id="Background_Orthos" class="heavy">Background</h3>
 +
                    <p>
 +
The next step was to assess the binding capacity of the streptavidin linker. Orthos, named after the guardian of Geryon's cattle, is a fusion protein between CBM3a and a monomeric streptavidin head. The strong affinity of streptavidin for biotin (dissociation constant of 10<sup>-13</sup> M) will allow biotinylated organic molecules to be tightly bound to Orthos. We used two types of biotinylated compounds to monitor the ability of our platform to functionalise cellulose:  fluorophores (mTagBFP and fluorescein) and antimicrobial peptide (scygonadin).  
 +
</p>
 +
 +
                    <h3 id="Key_Achievements_Orthos" class="heavy">Key Achievements</h3>
 +
                   
 +
                    <p>
 +
                    <ul>
 +
                    <li> <p><i>Cloning of the part encoding Orthos</i></p></li>
 +
                    <li> <p><i>Production of Orthos carrying monomeric streptavidin</i></p></li>
 +
                    <li> <p><i>Production of biotinylated fluorophores</i> in vitro <i>and</i> in vivo</p></li>
 +
<li> <p><i>Functionalisation of cellulose with biotinylated compounds</i></p></li>
 +
                    </ul>
 +
                    </p>
 +
                    <h3 id="Materials_Methods_Orthos" class="heavy">Materials and Methods</h3>
 +
                    <p>
 +
The fusion between monomeric streptavidin and CBM3a was cloned into the pET28 expression vector. The resulting construct was transformed into <i>E. coli</i> strain BL21 DE3 and expression of the recombinant protein was induced using IPTG. For Orthos, the histidine tag present on pET28 is not be fused to the CBM3a domain since an amber Stop codon is present between them (Figure 1). The protein was therefore not purified on the IMAC column but purified on Regenerated Amorphous Cellulose (RAC) and used in cellulose pull down assays. For the experimental details, see our <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Experiments">experiments page</a>.
 +
</p>
 +
<div style="text-align:center">
 +
<figure id="figure2" class="figure"  style="text-align:center;">
 +
  <img style="width : 60%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/7/70/T--Toulouse-INSA-UPS--Results--Youn--constructorthos.png" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
 +
<figcaption id="figcaption2" class="figure-caption"><strong>Figure 1:</strong> <i>Scheme of the Orthos construction </i></figcaption>
 +
</figure>
 +
  </div>
 +
                    <h3 id="Results_Discussion_Orthos" class="heavy">Results and Discussion</h3>
 +
                     <h4 id="Purification_Orthos" class="heavy">Purification of Orthos</h4>
 +
 
                      
 
                      
                    <div class="tab-pane fade" id="Safe_Part2" role="tabpanel">
+
<div style="text-align:center">
                            <h2 id="KR" class="heavy">Knowing the risks and minimize them</h2><hr/>
+
      <figure id="figure3" class="figure"  style="text-align:center;">
 +
        <img style="width : 45%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/d/d9/T--Toulouse-INSA-UPS--Collaborations--GB--SDSPAGE_Analysis2.jpg" class="figure-img img-fluid rounded" alt="SDS-PAGE">
 +
        <figcaption id="figcaption3" class="figure-caption"><strong>Figure 2:</strong> <i>SDS-PAGE analysis of purification of Orthos (S: supernatant, W1, W2: washes, E: elution, MW: molecular weight ladder)</i></figcaption>
 +
    </figure>
 +
    </div>
 +
<p>
 +
Figure 2 presents the results of the purification of Orthos on RAC. The supernatant (S) contained all proteins produced in <i>E. coli</i>, and washes W1 and W2 allowed the elimination of most non-specific interactions with cellulose. The elution step, using ethylene glycol, released the Orthos protein from RAC. The band at about 40 kDa corresponds to Orthos (expected size: 39 kDa) and the band at 15 kDa likely corresponds to a proteolysis fragment of Orthos containing only the CBM3a module.                    </p>
 +
<p>
 +
We estimated that the purification levels of the monomeric Orthos was about 45%, which is sufficient for our validation assays.
 +
                    </p>
  
                            <h3 id="KR-haz" class="heavy">Hazards we could met</h3>
+
  <h4 id="Validation_Orthos" class="heavy">Validation of monomeric Orthos</h4>
             
+
<h5 id="Validation_Invivo_Orthos" class="heavy">Validation using<i> in vivo </i>biotinylation</h5>
                              <p>In the laboratory, there is a large variety of risks we could met. We will detail what risks could occurs and how the LISBP managed them here.</p>
+
                    <p>
             
+
In a first set of experiments, we assessed the ability of Orthos to functionalise cellulose with a compound biotinylated <i>in vivo</i>. For that purpose, we took advantage of a novel system for <i>in vivo</i> protein biotinylation using the biotin ligase BirA. We thus co-expressed BirA and a version of the Blue Fluorescent Protein (BFP) fused to an Avitag in <i>E. coli</i>. The Avitag sequence is recognized by BirA for biotin ligation. We added biotin to the culture medium during IPTG induction, in order to produce and purify biotinylated BFP.</p>
                              <h4>Main hazards:</h4>
+
<p>We then incubated 3.2 &#956;M of Orthos with 32 &#956;M of <i>in vivo</i> biotinylated BFP (Figure 3). For the control experiment BFP (without Orthos), the same quantity of BFP was added to permit a relevant comparison. These samples were then incubated with cellulose. After three washes with Tris-HCl buffer, fluorescence was measured in the cellulose pellets. As shown in Figure 3, fluorescence is twice as intense in Orthos sample than in the control sample containing BFP alone. These experiments have been performed in quadruplicate and a Mann Whitney statistical test indicated that the increased fluorescence signal obtained with Orthos is significant.</p>
                              <p><u> External risks (earthquake, security issues…):</u></p>
+
                              <p>LISBP is concerned by many different types of hazards due to a wide spectrum of scientific activities. One hazard category gathers risks that are not directly linked to the LISBP research activity such as the risks due to working conditions (noise, thermal atmosphere, etc.), electrical hazards, work on computer screens, falls, etc. The main hazard categories concern the substances handled for research purposes such as class 1 microorganisms (GMO or not), urban wastewaters, chemical products among including CMRs, cryogenic fluids, etc… A second main hazard category relates to equipment and pilot plants with specific risks such as equipment using pressurized liquids, gases or steam (autoclaves), instruments generating non-ionizing radiations (Laser, UV lights) and electromagnetic radiations (RMN).</p>
+
             
+
               
+
                              <h4>Hazardous chemicals:</h4>
+
               
+
                              <p><u>List of hazardous, chemicals & inventory:</u></p>
+
               
+
                              <p>The list of hazardous, chemicals and inventory is managed independently by the each LISBP sub group. A common LISBP list of CMR substances is monitored and updated.</p>
+
               
+
                              <p><u>Waste management plan:</u></p>
+
               
+
                              <p>The chemical waste is managed in accordance with the environmental code. First, the waste is stored on a specially adapted LISBP/INSA site, before being disposed by a subcontracted service provider in accordance with the ADR rules concerning the waste treatment, valorization or destruction. Each waste removal is accompanied by tracking form for monitoring of hazardous waste.</p>
+
               
+
                              <p><u>Vacuum/pressurized equipment:</u></p>
+
               
+
                              <p>Pressurized equipment is monitored according to the Decree from 15 March 2000 concerning the work with the vacuum and high-pressure equipment.</p>
+
               
+
                              <p><u>Cryogenic/high temperature equipment:</u></p>
+
               
+
                              <p>Implementation of adequate means of prevention.</p>
+
               
+
                              <h4>Biological safety:</h4>
+
               
+
                              <p><u>Biological safety plan:</u></p>
+
               
+
                              <p>The laboratory applies the measures states in the articles of French Labour Code: L.4421-1 et R. 4421-1 a R. 4427-5 (Directive 90/619 on life insurance from 26 November 1990).</p>
+
               
+
                              <p><u>Biological material Type of organism used:</u></p>
+
               
+
                              <p>Prokaryotes, unicellular eukaryotes. Risk group: Risk group 1 Origin: E. coli and yeast mainly. Other biological: DNA, RNA... Facilities/Equipment Biosafety level: The majority of the LISBP facility is operated at Biosafety Level 1.</p>
+
               
+
                              <p><u>Biosafety cabinets:</u></p>
+
  
                              <figure class="figure"  style="text-align:center;">
+
<div style="text-align:center">
                                <img style="width : 70%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/e/e9/T--Toulouse-INSA-UPS--Microbiology-Security-Hood.jpg" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
+
      <figure id="figure4" class="figure"  style="text-align:center;">
                                <figcaption class="figure-caption"><strong>Figure 1:</strong> Microbiology Safety Hood at our lab</figcaption>
+
        <img style="width : 50%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/0/04/T--Toulouse-INSA-UPS--Collaborations--GB--FluoRetainedOrthos.jpg" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
                            </figure>
+
        <figcaption id="figcaption4" class="figure-caption"><strong>Figure 3:</strong> <i>Functionalisation of cellulose with Orthos bound to biotinylated BFP. Fluorescence remaining on cellulose fraction after several washes (*Mann Whitney test p-value 0.01)</i></figcaption>
               
+
    </figure>
                              <p>The use of PSM type II guarantee the sterility of the manipulation and the protection of the environment and of the manipulator.</p>
+
    </div>
               
+
                              <p><u>Decontamination plan:</u></p>
+
<p>
               
+
These results demonstrate that Orthos binds efficiently to an <i>in vivo</i> biotinylated compound. In addition, they show that Orthos binds to cellulose and thus provide proof of principle that Orthos design allows functionalisation of cellulose with a fluorophore through its streptavidin linker.  
                              <p>Certain laboratory rooms are subjected to gaseous decontamination once per year or upon request.</p>
+
</p>
               
+
                              <p><u>Biological waste management plan:</u></p>
+
               
+
                              <p>The biological waste (liquid or solid) is pretreated chemically (bleach) or by autoclaving. Glass, sharp or jagged objects are disposed via a specialized company (DASRI).</p>
+
<h5 id="Validation_Invitro_Orthos" class="heavy">Validation using <i>in vitro</i> chemical biotinylation</h5>
               
+
                    <p>
                              <p><u>Biological emergency plan (exposure spill):</u></p>
+
In a second set of experiments, we tested the ability of Orthos to functionalise cellulose with <i>in vitro</i> biotinylated compounds. Since we had both an azide-functionalised fluorescein (FAM-azide) and biotin-DBCO (an alkyne moiety), we imagined to combine both to produce biotinylated FITC. In addition, it was a nice way to challenge this click chemistry technology. We used the newly emerging technique Cu(I)-free strain-promoted alkyne-azide click chemistry (SPAAC) allowing the coupling <i>in vitro </i>of a molecule containing a dibenzocyclooctyne (DBCO) moiety to another molecule bearing an azide function. We used this technique to ligate <i>in vitro </i>biotin-DBCO to an azide-functionalised fluorescein (FITC), thus leading to the expected biotinylated FITC.  
               
+
                    </p>
                              <p>In case of exposure spill, the liquids are absorbed through suitable means and further treated as biological waste. </p>
+
               
+
<div style="text-align:center">
                            <h3 id="KR-haz" class="heavy">Good laboratory practices</h3>
+
      <figure id="figure5" class="figure"  style="text-align:center;">
               
+
        <img style="width : 45%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/5/52/T--Toulouse-INSA-UPS--Collaborations--angeline--FluoRetainedOrthos2.jpg" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
                              <p>We have received a formation about the safety in the lab that teaches us some basic rules. Those rules are listed in the summary diagram below.</p>
+
        <figcaption id="figcaption5" class="figure-caption"><strong>Figure 4:</strong> <i>Functionalisation of cellulose with Orthos bound to <i>in vitro</i>-biotinylated FITC. Fluorescence remaining on cellulose pellet fraction after several washes (quadruplicate test). (*Mann Whitney test p-value 0.1)</i></figcaption>
                                 
+
    </figure>
                    </div>
+
    </div>
                    <div class="tab-pane fade" id="Safe_Part3" role="tabpanel">
+
 +
<p>
 +
Then, 58.0 &#956;M of biotinylated FITC was incubated with 5.8 µM of Orthos protein. The same amount of FITC alone (58.0 &#956;M) was used for the control experiment. These samples were incubated with cellulose and after five washes with Tris-HCl buffer, fluorescence levels were measured in the cellulose pellet fractions (Figure 4). In the presence of Orthos, fluorescence in the cellulose pellet was about twice as high as in control experiments corresponding to the cellulose pellet incubated with FITC alone (without Orthos) or with the reaction buffer only. These experiments were performed in quadruplicate and a Mann Whitney statistical test indicated that the increased fluorescence signal obtained with Orthos is very significant. This result clearly shows that purified Orthos retains the ability to mediate the interaction between cellulose and a compound biotinylated <i>in vitro</i>. In addition, this result provides another strong evidence that Orthos allows cellulose to be functionalised using a fluorescent molecule through its streptavidin linker. It also shows that we succeeded in creating biotinylated FITC by click chemistry.</p>
 +
 +
<h5 id="Validation_Scygonadin_Orthos" class="heavy">Validation using scygonadin</h5>
 +
                    <p>
 +
In order to confirm that the streptavidin moiety of Orthos is able to interact with different kind of biotinylated compounds, we also tried to bind it to an antimicrobial peptide, the scygonadin. To biotinylate this compound, we used the <i>in vivo</i> protein biotinylation system as the one used for BFP molecule. We co-expressed BirA with a version of scygonadin fused to the Avitag in <i>Pichia pastoris</i>.
 +
</p>
  
                            <h2 id="SPC" class="heavy">Safety and project construction</h2><hr/>
+
<p>
 +
We then incubated Orthos with <i>in vivo</i> biotinylated scygonadin, and few hours later, we added cellulose (under form of a cellulose spot). After two washes with Tris-HCl buffer, cellulose spots with Orthos-scygonadin were deposed on Petri dish pre-inoculated with a <i>E. coli </i>layer. We observed small halos of inhibition for some samples after incubation overnight (Figure 5). </p>
 +
<div style="text-align:center">
 +
      <figure id="figure6" class="figure"  style="text-align:center;">
 +
        <img style="width : 55%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/5/55/T--Toulouse-INSA-UPS--Collaborations--angeline--Halo.jpg" class="figure-img img-fluid rounded" alt="Inhibition halo">
 +
        <figcaption id="figcaption6" class="figure-caption"><strong>Figure 5:</strong> <i>Halo of inhibition of Orthos alone (C), scygonadin alone (S) and Orthos+scygonadin (C+S) samples</i></figcaption>
 +
    </figure>
 +
    </div>
 +
<p>
 +
We noticed that the inhibition halo was more important for the Orthos-scygonadin sample than the scygonadin alone control. Unfortunately, we repeated this test, but we did not obtain the same result. Therefore, we need to improve our experiment to prove the coupling between Orthos and biotinylated scygonadin. These results are nevertheless encouraging in the perspective of functionalising cellulose using Orthos bound to antibiotic protein.
 +
</p>
 +
<h3 id="Perspectives_Orthos" class="heavy">Perspectives</h3>
 +
<hr/>
 +
<p>Our experiments using different kinds of biotinylated compounds provide convincing proofs of concept that Orthos can be conjugated, via its streptavidin head, to biotinylated organic molecules. The resulting molecules interact with cellulose and are therefore potent cellulose functionalising compounds. </p>
 +
<p>We can now envision exploiting the streptavidin linker of Orthos to ligate various compounds that can be biotinylated chemically (<i>in vitro</i>) or <i>in vivo</i>, via BirA co-expression.</p>
 +
<p>In addition, we incorporated a TEV protease cleavage between the <i>N</i>-terminus linker and the streptavidin. This will allow to produce Orthos-bound biotinylated compounds that can be released by TEV cleavage if required, as in the case of odorant molecules for examples for a commercial use. </p>
 +
</div>
 +
 +
<!--PART 3 : cerberus-->
 +
<div class="tab-pane fade" id="Results_Part3" role="tabpanel">
 +
<h2 id="Cerberus" class="heavy">Cerberus: AzF</h2>
 +
<hr/>
 +
 +
<h3 id="Background_Cerberus" class="heavy">Background</h3>
 +
                    <p>
 +
Cerberus, named after the guardian of the gates of the Underworld, is our three-headed protein made of the cellulose-binding molecular platform (CBM3a) fused at the N-terminus to the biotinylated molecule-binding head (monomeric streptavidin) and at the C-terminus to the unnatural amino acid azido-L-phenylalanine (AzF). The incorporation of AzF is achieved through the recognition of the amber stop codon at the C-terminus of CBM3a by an orthogonal AzF-charged tRNA.
 +
</p>
 +
 +
<figure id="figure6" class="figure"  style="text-align:center;">
 +
<img style="width : 55%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/8/85/T--Toulouse-INSA-UPS--Results--Youn--constructcerberus.png" class="figure-img img-fluid rounded" alt="Inhibition halo">
 +
<figcaption id="figcaption6" class="figure-caption"><strong>Figure 1:</strong> <i>Scheme of the Cerberus construction </i></figcaption>
 +
</figure>
 +
<p>
 +
Coupling of molecules to the AzF head can be performed by click chemistry, either through SPAAC or through Cu(I)-catalyzed azide-alkyne click chemistry (CuAAC). To prove the versatility of the system, different compounds such as fluorescent proteins or paramagnetic beads have been clicked onto Cerberus and thus associated with cellulose.
 +
</p>
 +
 +
                    <h3 id="Key_Achievements_Cerberus" class="heavy">Key Achievements</h3>
 +
                    <p>
 +
                    <ul>
 +
                    <li> <p><i>Cloning of the part encoding Cerberus</i></p></li>
 +
                    <li> <p><i>Production of Cerberus</i></p></li>
 +
                    <li> <p><i>Functionalisation of cellulose</i></p></li>
 +
                    </ul>
 +
                    </p>
 +
 +
                    <h3 id="Materials_Methods_Cerberus" class="heavy">Materials and Methods</h3>
 +
                    <p>
 +
The fusion between the streptavidin linker and the CBM3a domain sequences followed by the amber stop codon was cloned into the pET28 expression vector in fusion with the His-tag. The resulting construct was co-transformed into <i>E. coli</i> strain with the pEVOL expression vector. The latter allows to the expression of the amino acyl tRNA synthetase aaRS. In presence of AzF, this enzyme synthesizes the orthogonal AzF-tRNA for in vivo AzF incorporation in place of amber Stop codon. The Cerberus platform was produced by adding IPTG (Cerberus induction), L-arabinose (amino acyl tRNA synthetase production), and AzF to the medium. The His-tagged protein was then purified on IMAC resin charged with cobalt and used in cellulose pull down assays. For the experimental details, see <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Experiments">experiments page</a>.
 +
</p>
 +
                    <h3 id="Results_Discussion_Cerberus" class="heavy">Results and Discussion</h3>
 +
                    <h4 id="Purification_Cerberus" class="heavy">Production and purification of Cerberus</h4>
 +
<p>
 +
Cerberus production requires a deferred induction. We first induced the synthesis of aarS/tRNA pair with L-arabinose, and added AzF at the same time. One hour later, we induced the production of Cerberus with IPTG.
 +
</p>
 +
 +
                    <div style="text-align:center">
 +
      <figure id="figure7" class="figure"  style="text-align:center;">
 +
        <img style="width : 28%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/7/70/T--Toulouse-INSA-UPS--Collaborations--angeline--SDSPAGE_cerberus.jpg" class="figure-img img-fluid rounded" alt="SDS-PAGE">
 +
        <figcaption id="figcaption7" class="figure-caption"><strong>Figure 2:</strong> <i>SDS-PAGE analysis of the production of Cerberus with monomeric streptavidin (NI: non-induced, I-AzF: induced without AzF, I+AzF: induced with AzF, E1: elution with 40 mM imidazole, E2: elution with 100 mM imidazole, E3: elution with 100 mM imidazole, MW: molecular weight ladder)</i></figcaption>
 +
    </figure>
 +
    </div>
 +
 +
<p>
 +
Cerberus production and purification were analysed on SDS gel (Figure 2). Induction in the presence of AzF (Figure 2, lane I+AzF) led to the expression of two major bands at 37 and 39 kDa approximately compared to control conditions, namely the non-induced (lane NI) and induced without AzF (lane I-AzF). We hypothesized that the upper band would correspond to Cerberus (expected molecular weight of Cerberus with monomeric streptavidin: 41 kDa) and the lower bands to the Orthos proteins (Cerberus without the AzF and the His-tag). Surprisingly, both bands were present in the elution fractions which is incoherent since Orthos lacks an His-tag and was supposed to be washed out during purification steps. To confirm our hypothesis, we analysed the same fractions by western blot using antibodies detecting the His-tag (Figure 3).
 +
</p>
 +
 +
<div style="text-align:center">
 +
      <figure id="figure8" class="figure"  style="text-align:center;">
 +
        <img style="width : 35%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/0/01/T--Toulouse-INSA-UPS--Collaborations--angeline--SDSPAGE_cerberus2.jpg" class="figure-img img-fluid rounded" alt="Western blot">
 +
        <figcaption id="figcaption8" class="figure-caption"><strong>Figure 3:</strong> <i>Western blot analysis of Cerberus production (NI: non-induced, I-AzF: induced without AzF, I+AzF: induced with AzF, E: elution, MW: molecular weight ladder)</i></figcaption>
 +
    </figure>
 +
    </div>
 +
 +
<p>
 +
Anti-His-tag antibodies revealed a band at about 45 kDa in the sample corresponding to IPTG induction in the presence of AzF (Figure 3, lane I+AzF). This band is not present in control samples (Figure 3, lane NI and I-AzF), indicating that it corresponds to the Cerberus protein (theoretical size: 41 kDa). In addition to the full length protein, we observed several extra bands which very likely correspond to proteolysis products since they are detected with the anti-His-tag antibodies. Moreover, the band at 45 kDa is clearly detected in elution samples (Figure 3, lanes E). The band at 37 kDa observed on the SDS PAGE (Figure 2) is not observed on the Western blot. These results show that the experimental setup to produce Cerberus is also likely leading to the production of Orthos when the amber stop codon is not recognized by the AzF-charged orthogonal tRNA. Although Orthos does not contain a His-tag at its C-terminus, the protein seems to be efficiently co-purified with Cerberus. The basis of this observation is unclear but it may suggest that Orthos and Cerberus interact with each other, via their CBM3 or streptavidin moieties. 
 +
</p>
 +
<p>We estimated that the purification level of Cerberus with monomeric streptavidin in the elution samples was about 62%. These data show that Cerberus was efficiently purified and can be used for pull down assays. </p>
 +
 +
                    <h4 id="Validation_Cerberus" class="heavy">Validation</h4>
 +
<h5 id="Validation_Invivo_Cerberus" class="heavy">Validation using FITC (Fluorescein isothiocyanate) molecules</h5>
 +
                   
 +
<div style="text-align:center">
 +
      <figure id="figure7" class="figure"  style="text-align:center;">
 +
        <img style="width : 50%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/f/f8/T--Toulouse-INSA-UPS--Collaborations--angeline--FluoRetainedCerberus.jpg" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
 +
        <figcaption id="figcaption7" class="figure-caption"><strong>Figure 4:</strong> <i>Functionalisation of cellulose with FITC conjugated to Cerberus. Fluorescence remaining in cellulose fraction after several washes (quadruplicate test). (*Mann Whitney test p-value 0.03)</i></figcaption>
 +
    </figure>
 +
    </div>
 +
<p>
 +
To test the potential of Cerberus in functionalising cellulose, we monitored its ability to mediate an interaction between cellulose and a fluorescent compound. To generate a fluorescently labelled Cerberus protein, we performed a SPAAC reaction on 3.2 µM Cerberus protein using 31.9 µM of FITC-DBCO. In control experiment, 31.9 µM of FITC alone was used. These samples were then incubated with cellulose and after five washes with Tris-HCl buffer, fluorescence levels were measured in the cellulose pellet fractions (Figure 9). We observed that the fluorescence levels in the cellulose pellet incubated with Cerberus protein clicked to FITC were about 3 times higher than in the control experiments corresponding to the cellulose pellet incubated with FITC alone. These results show that Cerberus can efficiently be conjugated to fluorescent molecules bearing a DBCO group by click chemistry and that the resulting fluorescent molecules strongly interact with cellulose. Therefore, Cerberus is both a convenient and potent platform to functionalise cellulose.
 +
                    </p>
 +
 +
 +
<h5 id="Validation_Invitro_Cerberus" class="heavy">Validation using paramagnetic beads</h5>
 +
                    <p>
 +
We further characterize the functionality of Cerberus in a second set of experiments  using paramagnetic beads. To bind paramagnetic beads to Cerberus, we performed a click reaction using 3.2 µM of Cerberus protein and  32 µM DBCO-conjugated paramagnetic beads. As a control experiment, 32 µM of paramagnetic beads were used. These samples were then incubated with cellulose, and after five washes with Tris-HCl buffer, we measured the magnetisation of cellulose using a magnet.
 +
                    </p>
 +
<div style="text-align:center">
 +
      <figure id="video1" class="figure"  style="text-align:center;">
 +
        <video controls preload="auto" muted="true" style="width : 80%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/1/14/T--Toulouse-INSA-UPS--Collaborations--angeline--ferocell.MOV" alt="Magnetic cellulose">
 +
       
 +
</video>
 +
    <figcaption id="vidcaption" class="figure-caption"><b>Figure 5:</b> <i>Video of the Cerberus-functionalised paramagnetic cellulose: on the left, control with paramagnetic beads alone; on the right, Cerberus-paramagnetic beads.</i></figcaption>
  
                            <p>Safety management, french legislation and ethics took an important part in the way we managed our project. The brainstorming have been particularly affected by those points. Indeed, we wanted to work on a project that can live outside the iGEM competition and outside the lab. So, very soon, we select our ideas depending on “will the use of GMOs become an issue for the safety of the customer by also for the environment”. Our project Cerberus need GMOs but we develop it to avoid any contact with the user of the product but also with the environnement. At the end, we produce a protein in laboratory with GMOs but only the protein, and not the organism that produced it, is used.</p>
+
    </figure>
                            <p>If this part of the construction of our project interest you, we invite you to read the <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Human_Practices">Human Practices section</a>.</p>
+
    </div>
                               
+
<p>
                    </div>
+
As observed on the video (Figure 5), the cellulose incubated with the Cerberus protein conjugated to paramagnetic beads is quickly and totally attracted by the magnet. In contrast, in the control experiment, no clear movement towards the magnet was observed.  
                </div>
+
</p>
            </div>
+
 +
<p>
 +
These results show that Cerberus has the ability to interact simultaneously with cellulose and molecules with a DBCO group, confirming that the Cerberus platform allows to functionalise cellulose through its linker containing unnatural amino acid.
 +
</p>
 +
 +
<h4 id="Validation_Scygonadin_Cerberus" class="heavy">Towards other functionalisations</h4>
 +
                    <p>
 +
To go further in our project, we decided to functionalise two inorganic molecules, graphene and carbon nanotubes (CNT), using a reaction of diazotization. This experiment was performed with the help of the ENSIACET laboratory in Toulouse. To check functionalisation, we analysed samples by Thermogravimetric Analysis (TGA). The concept of TGA consists of measuring the mass change of a sample depending on temperature and time, in a controlled atmosphere. We chose to perform the experiment under nitrogen, N<sub>2</sub>, an inert gas that avoids mass loss by oxidation, and we studied the mass change from 25 to 1,000 °C (15 °C/min). 
 +
                    </p>
 +
 +
<!-- <div style="text-align:left; background-color:yellow"> -->
 +
      <figure id="figure10" class="figure"  style=" width:50%; float:left; text-align:center;">
 +
        <img style="width:100%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/e/ed/T--Toulouse-INSA-UPS--Collaborations--angeline--massloss1.jpg" class="figure-img img-fluid rounded" alt="Mass loss">
 +
        <figcaption id="figcaption10" class="figure-caption"><strong>Figure 6:</strong> <i>Analysis of mass loss for functionalised CNT sample</i></figcaption>
 +
    </figure>
 +
    <!-- </div> -->
 +
 +
<!-- <div style="text-align:right"> -->
 +
      <figure id="figure11" class="figure"  style=" width:50%; float:left; text-align:center;">
 +
        <img style="width : 100%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/c/cb/T--Toulouse-INSA-UPS--Collaborations--angeline--massloss2.jpg" class="figure-img img-fluid rounded" alt="Mass loss">
 +
        <figcaption id="figcaption11" class="figure-caption"><strong>Figure 7:</strong> <i>Analysis of mass loss for non-functionalised CNT sample</i></figcaption>
 +
    </figure>
 +
    <!-- </div> -->
 +
 +
<p>
 +
Figures 6 and 7 present the results of mass loss for non-activated Carbon Nanotube (CNT) and activated CNT samples, respectively. For activated CNT sample (Figure 7), we observed a mass loss of 27.4% around 100 °C corresponding to water loss. A second step of mass loss is observed around 550 °C, with a diminution of 19.8%. For the non-activated sample (Figure 6), we observed two mass losses at 150 and 750 °C corresponding to 1.5% and 3% of mass loss respectively. The significative difference between these two samples allowed us to conclude that the CNT activation has been successful.
 +
</p>
 +
 +
<!-- <div style="text-align:center"> -->
 +
      <figure id="figure12" class="figure"  style="width:50%; float:left; text-align:center;">
 +
        <img style="width :100%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/1/1e/T--Toulouse-INSA-UPS--Collaborations--angeline--massloss3.jpg" class="figure-img img-fluid rounded" alt="Mass loss">
 +
        <figcaption id="figcaption12" class="figure-caption"><strong>Figure 8:</strong> <i>Analysis of mass loss for activated graphene sample</i></figcaption>
 +
    </figure>
 +
    <!-- </div> -->
 +
 +
<!-- <div style="text-align:center"> -->
 +
      <figure id="figure13" class="figure"  style="width:50%; float:right; text-align:center;">
 +
        <img style="width : 100%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/4/40/T--Toulouse-INSA-UPS--Collaborations--angeline--massloss4.jpg" class="figure-img img-fluid rounded" alt="Mass loss">
 +
        <figcaption id="figcaption13" class="figure-caption"><strong>Figure 9:</strong> <i>Analysis of mass loss for non-activated graphene sample</i></figcaption>
 +
    </figure>
 +
    <!-- </div> -->
 +
 +
<p>
 +
Figures 8 and 9 present the results of mass loss for non-activated graphene and activated graphene samples respectively. For activated graphene sample (Figure 9), we observed a mass loss of 31.0% around 100 °C corresponding to water loss. A second step of mass loss is observed around 500 °C, with a diminution of 19.0%. For the non-activated sample (Figure 8), we did not observe a significative mass loss. So we can conclude that the graphene activation has been successful.
 +
</p>
 +
<p>
 +
Our initial plan was to functionalise cellulose with CNT and graphene in order to change cellulose fibre rigidity and create conductive cellulose, respectively. Unfortunately, we did not have enough time during the course of the iGEM competition to complete these tests. Given the success of the other functionalisation, we have reasonable hopes that these experiments will be successful too.
 +
</p>
 +
 +
<h3 id="Perspectives_Cerberus" class="heavy">Perspectives</h3>
 +
<p>
 +
Our experiments provide robust proofs of concept that Cerberus can be conjugated, via its unnatural amino acid AzF, to organic or inorganic molecules bearing a DBCO group by click chemistry. The resulting molecules strongly interact with cellulose and are therefore potent cellulose functionalising compounds.
 +
</p>
 +
<p>
 +
We can now consider fixation of various compounds that can be chemically functionalised. We can also imagine double fixations, for example a fluorophore on the streptavidin head and paramagnetic beads on the AzF linker. This double fixation allows us to envision endless possibilities to functionalise cellulose (see <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Demonstrate">Demonstrate</a>).  
 +
</p>
  
  
 +
</div>
  
 +
<!--PART 4 : cellulose-->
 +
<div class="tab-pane fade" id="Results_Part4"  role="tabpanel">
 +
<h2 id="Bacterial Cellulose" class="heavy">Bacterial Cellulose production and functionalisation</h2>
 +
<hr/>
 +
 +
<h3 id="Background_Cellulose" class="heavy">Background</h3>
 +
                    <p>
 +
Our ultimate dream was to be able to produce functionalised cellulose <i>in vivo</i>. Some microorganisms naturally produce cellulose. One of these, <i>Gluconacetobacter hansenii</i>, can produce cellulose as a biofilm to protect itself. We took advantage of the work of iGEM Imperial team 2014 who set up culture conditions to optimize cellulose production. Our challenge was to assess if our technology is compatible with bacterial cellulose as a first step before producing functionalised cellulose <i>in vivo</i>.
 +
</p>
 +
 +
                    <h3 id="Key_Achievements_Cellulose" class="heavy">Key Achievements</h3>
 +
                    <p>
 +
                    <ul>
 +
                    <li> <p><i>Production of about 100g of dried bacterial cellulose</i></p></li>
 +
                    <li> <p><i>Functionalisation of bacterial cellulose with Sirius</i></p></li>
 +
                    </ul>
 +
                    </p>
 +
 +
                    <h3 id="Materials_Methods_Cellulose" class="heavy">Materials and Methods</h3>
 +
                    <p>
 +
<i>G. hansenii </i>was grown in Hestrin-Shramm (HS) medium at 30 °C. After one week of culture, bacterial cellulose was extracted and purified.  For the experimental details, see our <a href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Experiments">experiments page</a>.
 +
</p>
 +
<p>
 +
For the functionalisation, bacterial cellulose was incubated with purified Sirius (CBM3a-mRFP1) or with purified mRFP1 alone as a control. Cellulose was then washed about 10 times with Tris-HCl buffer buffer to remove non-attached proteins.
 +
</p>
 +
 +
                    <h3 id="Results_Discussion_Cellulose" class="heavy">Results and Discussion</h3>
 +
<div style="text-align:center">
 +
      <figure id="figure14" class="figure"  style="text-align:center;">
 +
        <img style="width : 100%; heigth = auto;" src="https://static.igem.org/mediawiki/2018/d/d2/T--Toulouse-INSA-UPS--Results--Youn--celluloseUV.jpg" class="figure-img img-fluid rounded" alt="Fluorescence Retained">
 +
        <figcaption id="figcaption14" class="figure-caption"><strong>Figure 1: a)</strong> <i>Picture of functionalised cellulose with Sirius (CBM3a fused with mRFP1). Left: control mRFP1 alone; Right: Sirius ;</i><strong>b) </strong><i>Picture under UV of functionalised cellulose with Sirius (CBM3a fused with mRFP1). Left: control mRFP1 alone; Right: Sirius </i></figcaption>
 +
    </figure>
 +
</div>
  
 +
<p>
 +
Figure 1a presents the results of the functionalisation of our bacterial cellulose with the Sirius fluorescent protein. Only the cellulose sample incubated with Sirius kept the color after several washes with resuspension buffer. Likewise fluorescence remained associated to cellulose only for Sirius (Figure 1b). These results show that CBM3a can interact with the bacterial cellulose and allows fixation of the mRFP1 protein to cellulose.
 +
</p>
  
 +
<h3 id="Perspectives_Cellulose" class="heavy">Perspectives</h3>
 +
<p>
 +
Now that we have proved the capacity of CBM3a to interact with bacterial cellulose, we are confident that Orthos and Cerberus proteins should also interact with bacterial cellulose. Now the next step will be to produce functionalised bacterial cellulose <i>in vivo </i>. For this, we had planned to produce the Cerberus platform in the yeast <i>Pichia pastoris</i> because of its secretion capacity. Indeed, our idea was to co-culture both strains in the same reactor in order to produce functionalised cellulose <i>in vivo</i>. This work on <i>P. pastoris</i> was performed at the same time as our attempt in <i>E. coli</i> but has not been as successful. We managed to produce the Orthos protein in the yeast but we never succeeded in producing Sirius and we never got the plasmid needed to produce the tRNA synthetase necessary for AzF incorporation in <i>P. pastoris</i>. In addition, the production of Orthos in the yeast was very low and not sufficient to conduct our assays. So production of functionalised cellulose <i>in vivo</i> will require improving the <i>P. pastoris </i>part of our project.
 +
</p>
 +
 +
</div>
 +
</div>
 +
 +
</div>
  
</div>
 
 
<!--CONTENT ENDS HERE-->
 
<!--CONTENT ENDS HERE-->
 
</div> </html> {{Template:Toulouse-INSA-UPS/CONTENT-END}} <html>
 
</div> </html> {{Template:Toulouse-INSA-UPS/CONTENT-END}} <html>
 
<div id="NAV_ICON_BAR" class="nav-left-col sticky-bottom d-none d-xl-block">
 
<div id="NAV_ICON_BAR" class="nav-left-col sticky-bottom d-none d-xl-block">
 
<ul class="nav justify-content-center">
 
<ul class="nav justify-content-center">
  <li class="nav-item">
+
 
<!--To previous page-->
+
<li class="nav-item">
  <a class="nav-link ico" href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Parts">
+
<img class="ico" src="https://static.igem.org/mediawiki/2018/d/db/T--Toulouse-INSA-UPS--All--Yohann--Left_Arrow.png" alt="Left Arrow"/>
+
</a>
+
  </li>
+
  <li class="nav-item">
+
 
<!--Anchor to TOP-->
 
<!--Anchor to TOP-->
 
   <a class="nav-link ico" href="#TOP">
 
   <a class="nav-link ico" href="#TOP">
Line 180: Line 431:
 
</a>
 
</a>
 
   </li>
 
   </li>
   <li class="nav-item">
+
  
<!--to next page-->
+
  <a class="nav-link ico" href="https://2018.igem.org/Team:Toulouse-INSA-UPS/Human_Practices">
+
<img class="ico" src="https://static.igem.org/mediawiki/2018/3/36/T--Toulouse-INSA-UPS--All--Yohann--Right_Arrow.png" alt="Right Arrow"/>
+
</a>
+
  </li>
+
 
</ul>
 
</ul>
 
</div>
 
</div>

Latest revision as of 12:21, 17 October 2018

RESULTS


The whole Cerberus project is based on the construction and validation of a proteic platform to link very different molecules together. This platform is composed of three heads. The first head is a CBM3a domain which specifically binds cellulose. The second head is a streptavidin domain with a strong affinity to biotinylated compounds. The third head is based on the presence of an unnatural amino acid to covalently link any molecule with an alkyne moiety.

To validate the Cerberus platform, we worked head by head, starting from the CBM3a validation, then the streptavidin domain assessment and finally the demonstration of the unnatural amino acid capacity to covalently bound alkynilated molecules. Thus, our first construction has only one head and was named Sirius, after the brightest star of the northern hemisphere, alpha canis majoris. The second construction presents both the CBM3a and streptavidin heads and was nicknamed Orthos, a two-headed mythological dog. The final construction is Cerberus with its three heads.

A banner

Sirius: CBM3a


Background

Sirius is a fusion protein between CBM3a and mRFP1. This design, which consists of fusing CBM3a to a fluorescent moiety, allowed us to investigate the binding capability of the CBM3a domain to cellulose through the four aromatic amino acids of its binding domain. mRFP1 was chosen since it is both a coloured and fluorescent protein.

Key Achievements

  • Cloning of the part encoding Sirius

  • Overexpression and purification of Sirius

  • Fixation of Sirius to cellulose

Materials and Methods

The fused CBM3a and mRFP1 sequences were cloned into the pET28 expression vector in fusion with a histidine tag (Figure 1).

A generic square placeholder image with rounded corners in a figure.
Figure 1: Scheme of the Sirius construction

The resulting construct was transformed into E. coli strain and expression of the recombinant protein was induced using IPTG. The His-tagged protein was then purified on IMAC resin charged with cobalt and used in cellulose pull down assays. For the experimental details, see Experiments page.

Results and Discussion

Production and purification of Sirius

Interestingly, E. coli turned a deep pink shade after induction, indicating a strong production of Sirius (Figure 2).

SDS Page
Figure 2: E. coli expressing Sirius
SDS Page
Figure 3: SDS-PAGE analysis of Sirius purification. (CFE: cell free extract, FT: flow through, W: washes, E1/40: elution with 40mM imidazole, E1/100: elution with 100 mM imidazole, E2/100: elution with 100 mM imidazole, E1/300: elution with 300 mM imidazole, MW: molecular weight ladder.)

As shown in Figure 3, we successfully purified the Sirius protein. Indeed, induction with IPTG produced a large amount of a protein at the expected size for Sirius (52 kDa, lane CFE). This protein was then found to be predominant in elution samples (E1/40 and E1/100). We estimated the degree of purity of full-length Sirius at about 72%. In addition to the full-length protein, we observed several extra bands that likely correspond to proteolysis products.

Validation

Once produced in , Sirius binding to cellulose was tested using pull down assays. 70 μM of Sirius protein or mRFP1 (without CBM3a) or buffer were incubated with cellulose. After five washes with Tris-HCl buffer, cellulose pellets were recovered and the associated fluorescence was measured.

When mRFP1 was added alone to cellulose, its associated colour mostly remained in the supernatant (Figure 4). When Sirius was associated with cellulose, the pinkish colour was clearly associated to the cellulose pellet. Quantification of the cellulose-associated fluorescence backed up these observations (Figure 5): control experiments showed that only background levels of fluorescence are retained in the cellulose pellet incubated with mRFP1 alone. These experiments have been performed in triplicate and statistical analyses indicate that the high level of fluorescence obtained with Sirius is definitively significant. These results clearly show that the CBM3a domain of Sirius interacts with cellulose, and thus mediates binding of mRFP1 protein to cellulose.

Fluorescence Retained
Figure 4: Picture of cellulose pull-down assay with mRFP1 alone (left tube) or with the Sirius construction (right tube)
Fluorescence Retained
Figure 5: Binding of Sirius to cellulose. Fluorescence retained in the cellulose pellet after pull down (triplicate test)

Orthos: Streptavidin and biotinylated compounds


Background

The next step was to assess the binding capacity of the streptavidin linker. Orthos, named after the guardian of Geryon's cattle, is a fusion protein between CBM3a and a monomeric streptavidin head. The strong affinity of streptavidin for biotin (dissociation constant of 10-13 M) will allow biotinylated organic molecules to be tightly bound to Orthos. We used two types of biotinylated compounds to monitor the ability of our platform to functionalise cellulose: fluorophores (mTagBFP and fluorescein) and antimicrobial peptide (scygonadin).

Key Achievements

  • Cloning of the part encoding Orthos

  • Production of Orthos carrying monomeric streptavidin

  • Production of biotinylated fluorophores in vitro and in vivo

  • Functionalisation of cellulose with biotinylated compounds

Materials and Methods

The fusion between monomeric streptavidin and CBM3a was cloned into the pET28 expression vector. The resulting construct was transformed into E. coli strain BL21 DE3 and expression of the recombinant protein was induced using IPTG. For Orthos, the histidine tag present on pET28 is not be fused to the CBM3a domain since an amber Stop codon is present between them (Figure 1). The protein was therefore not purified on the IMAC column but purified on Regenerated Amorphous Cellulose (RAC) and used in cellulose pull down assays. For the experimental details, see our experiments page.

Fluorescence Retained
Figure 1: Scheme of the Orthos construction

Results and Discussion

Purification of Orthos

SDS-PAGE
Figure 2: SDS-PAGE analysis of purification of Orthos (S: supernatant, W1, W2: washes, E: elution, MW: molecular weight ladder)

Figure 2 presents the results of the purification of Orthos on RAC. The supernatant (S) contained all proteins produced in E. coli, and washes W1 and W2 allowed the elimination of most non-specific interactions with cellulose. The elution step, using ethylene glycol, released the Orthos protein from RAC. The band at about 40 kDa corresponds to Orthos (expected size: 39 kDa) and the band at 15 kDa likely corresponds to a proteolysis fragment of Orthos containing only the CBM3a module.

We estimated that the purification levels of the monomeric Orthos was about 45%, which is sufficient for our validation assays.

Validation of monomeric Orthos

Validation using in vivo biotinylation

In a first set of experiments, we assessed the ability of Orthos to functionalise cellulose with a compound biotinylated in vivo. For that purpose, we took advantage of a novel system for in vivo protein biotinylation using the biotin ligase BirA. We thus co-expressed BirA and a version of the Blue Fluorescent Protein (BFP) fused to an Avitag in E. coli. The Avitag sequence is recognized by BirA for biotin ligation. We added biotin to the culture medium during IPTG induction, in order to produce and purify biotinylated BFP.

We then incubated 3.2 μM of Orthos with 32 μM of in vivo biotinylated BFP (Figure 3). For the control experiment BFP (without Orthos), the same quantity of BFP was added to permit a relevant comparison. These samples were then incubated with cellulose. After three washes with Tris-HCl buffer, fluorescence was measured in the cellulose pellets. As shown in Figure 3, fluorescence is twice as intense in Orthos sample than in the control sample containing BFP alone. These experiments have been performed in quadruplicate and a Mann Whitney statistical test indicated that the increased fluorescence signal obtained with Orthos is significant.

Fluorescence Retained
Figure 3: Functionalisation of cellulose with Orthos bound to biotinylated BFP. Fluorescence remaining on cellulose fraction after several washes (*Mann Whitney test p-value 0.01)

These results demonstrate that Orthos binds efficiently to an in vivo biotinylated compound. In addition, they show that Orthos binds to cellulose and thus provide proof of principle that Orthos design allows functionalisation of cellulose with a fluorophore through its streptavidin linker.

Validation using in vitro chemical biotinylation

In a second set of experiments, we tested the ability of Orthos to functionalise cellulose with in vitro biotinylated compounds. Since we had both an azide-functionalised fluorescein (FAM-azide) and biotin-DBCO (an alkyne moiety), we imagined to combine both to produce biotinylated FITC. In addition, it was a nice way to challenge this click chemistry technology. We used the newly emerging technique Cu(I)-free strain-promoted alkyne-azide click chemistry (SPAAC) allowing the coupling in vitro of a molecule containing a dibenzocyclooctyne (DBCO) moiety to another molecule bearing an azide function. We used this technique to ligate in vitro biotin-DBCO to an azide-functionalised fluorescein (FITC), thus leading to the expected biotinylated FITC.

Fluorescence Retained
Figure 4: Functionalisation of cellulose with Orthos bound to in vitro-biotinylated FITC. Fluorescence remaining on cellulose pellet fraction after several washes (quadruplicate test). (*Mann Whitney test p-value 0.1)

Then, 58.0 μM of biotinylated FITC was incubated with 5.8 µM of Orthos protein. The same amount of FITC alone (58.0 μM) was used for the control experiment. These samples were incubated with cellulose and after five washes with Tris-HCl buffer, fluorescence levels were measured in the cellulose pellet fractions (Figure 4). In the presence of Orthos, fluorescence in the cellulose pellet was about twice as high as in control experiments corresponding to the cellulose pellet incubated with FITC alone (without Orthos) or with the reaction buffer only. These experiments were performed in quadruplicate and a Mann Whitney statistical test indicated that the increased fluorescence signal obtained with Orthos is very significant. This result clearly shows that purified Orthos retains the ability to mediate the interaction between cellulose and a compound biotinylated in vitro. In addition, this result provides another strong evidence that Orthos allows cellulose to be functionalised using a fluorescent molecule through its streptavidin linker. It also shows that we succeeded in creating biotinylated FITC by click chemistry.

Validation using scygonadin

In order to confirm that the streptavidin moiety of Orthos is able to interact with different kind of biotinylated compounds, we also tried to bind it to an antimicrobial peptide, the scygonadin. To biotinylate this compound, we used the in vivo protein biotinylation system as the one used for BFP molecule. We co-expressed BirA with a version of scygonadin fused to the Avitag in Pichia pastoris.

We then incubated Orthos with in vivo biotinylated scygonadin, and few hours later, we added cellulose (under form of a cellulose spot). After two washes with Tris-HCl buffer, cellulose spots with Orthos-scygonadin were deposed on Petri dish pre-inoculated with a E. coli layer. We observed small halos of inhibition for some samples after incubation overnight (Figure 5).

Inhibition halo
Figure 5: Halo of inhibition of Orthos alone (C), scygonadin alone (S) and Orthos+scygonadin (C+S) samples

We noticed that the inhibition halo was more important for the Orthos-scygonadin sample than the scygonadin alone control. Unfortunately, we repeated this test, but we did not obtain the same result. Therefore, we need to improve our experiment to prove the coupling between Orthos and biotinylated scygonadin. These results are nevertheless encouraging in the perspective of functionalising cellulose using Orthos bound to antibiotic protein.

Perspectives


Our experiments using different kinds of biotinylated compounds provide convincing proofs of concept that Orthos can be conjugated, via its streptavidin head, to biotinylated organic molecules. The resulting molecules interact with cellulose and are therefore potent cellulose functionalising compounds.

We can now envision exploiting the streptavidin linker of Orthos to ligate various compounds that can be biotinylated chemically (in vitro) or in vivo, via BirA co-expression.

In addition, we incorporated a TEV protease cleavage between the N-terminus linker and the streptavidin. This will allow to produce Orthos-bound biotinylated compounds that can be released by TEV cleavage if required, as in the case of odorant molecules for examples for a commercial use.

Cerberus: AzF


Background

Cerberus, named after the guardian of the gates of the Underworld, is our three-headed protein made of the cellulose-binding molecular platform (CBM3a) fused at the N-terminus to the biotinylated molecule-binding head (monomeric streptavidin) and at the C-terminus to the unnatural amino acid azido-L-phenylalanine (AzF). The incorporation of AzF is achieved through the recognition of the amber stop codon at the C-terminus of CBM3a by an orthogonal AzF-charged tRNA.

Inhibition halo
Figure 1: Scheme of the Cerberus construction

Coupling of molecules to the AzF head can be performed by click chemistry, either through SPAAC or through Cu(I)-catalyzed azide-alkyne click chemistry (CuAAC). To prove the versatility of the system, different compounds such as fluorescent proteins or paramagnetic beads have been clicked onto Cerberus and thus associated with cellulose.

Key Achievements

  • Cloning of the part encoding Cerberus

  • Production of Cerberus

  • Functionalisation of cellulose

Materials and Methods

The fusion between the streptavidin linker and the CBM3a domain sequences followed by the amber stop codon was cloned into the pET28 expression vector in fusion with the His-tag. The resulting construct was co-transformed into E. coli strain with the pEVOL expression vector. The latter allows to the expression of the amino acyl tRNA synthetase aaRS. In presence of AzF, this enzyme synthesizes the orthogonal AzF-tRNA for in vivo AzF incorporation in place of amber Stop codon. The Cerberus platform was produced by adding IPTG (Cerberus induction), L-arabinose (amino acyl tRNA synthetase production), and AzF to the medium. The His-tagged protein was then purified on IMAC resin charged with cobalt and used in cellulose pull down assays. For the experimental details, see experiments page.

Results and Discussion

Production and purification of Cerberus

Cerberus production requires a deferred induction. We first induced the synthesis of aarS/tRNA pair with L-arabinose, and added AzF at the same time. One hour later, we induced the production of Cerberus with IPTG.

SDS-PAGE
Figure 2: SDS-PAGE analysis of the production of Cerberus with monomeric streptavidin (NI: non-induced, I-AzF: induced without AzF, I+AzF: induced with AzF, E1: elution with 40 mM imidazole, E2: elution with 100 mM imidazole, E3: elution with 100 mM imidazole, MW: molecular weight ladder)

Cerberus production and purification were analysed on SDS gel (Figure 2). Induction in the presence of AzF (Figure 2, lane I+AzF) led to the expression of two major bands at 37 and 39 kDa approximately compared to control conditions, namely the non-induced (lane NI) and induced without AzF (lane I-AzF). We hypothesized that the upper band would correspond to Cerberus (expected molecular weight of Cerberus with monomeric streptavidin: 41 kDa) and the lower bands to the Orthos proteins (Cerberus without the AzF and the His-tag). Surprisingly, both bands were present in the elution fractions which is incoherent since Orthos lacks an His-tag and was supposed to be washed out during purification steps. To confirm our hypothesis, we analysed the same fractions by western blot using antibodies detecting the His-tag (Figure 3).

Western blot
Figure 3: Western blot analysis of Cerberus production (NI: non-induced, I-AzF: induced without AzF, I+AzF: induced with AzF, E: elution, MW: molecular weight ladder)

Anti-His-tag antibodies revealed a band at about 45 kDa in the sample corresponding to IPTG induction in the presence of AzF (Figure 3, lane I+AzF). This band is not present in control samples (Figure 3, lane NI and I-AzF), indicating that it corresponds to the Cerberus protein (theoretical size: 41 kDa). In addition to the full length protein, we observed several extra bands which very likely correspond to proteolysis products since they are detected with the anti-His-tag antibodies. Moreover, the band at 45 kDa is clearly detected in elution samples (Figure 3, lanes E). The band at 37 kDa observed on the SDS PAGE (Figure 2) is not observed on the Western blot. These results show that the experimental setup to produce Cerberus is also likely leading to the production of Orthos when the amber stop codon is not recognized by the AzF-charged orthogonal tRNA. Although Orthos does not contain a His-tag at its C-terminus, the protein seems to be efficiently co-purified with Cerberus. The basis of this observation is unclear but it may suggest that Orthos and Cerberus interact with each other, via their CBM3 or streptavidin moieties.

We estimated that the purification level of Cerberus with monomeric streptavidin in the elution samples was about 62%. These data show that Cerberus was efficiently purified and can be used for pull down assays.

Validation

Validation using FITC (Fluorescein isothiocyanate) molecules
Fluorescence Retained
Figure 4: Functionalisation of cellulose with FITC conjugated to Cerberus. Fluorescence remaining in cellulose fraction after several washes (quadruplicate test). (*Mann Whitney test p-value 0.03)

To test the potential of Cerberus in functionalising cellulose, we monitored its ability to mediate an interaction between cellulose and a fluorescent compound. To generate a fluorescently labelled Cerberus protein, we performed a SPAAC reaction on 3.2 µM Cerberus protein using 31.9 µM of FITC-DBCO. In control experiment, 31.9 µM of FITC alone was used. These samples were then incubated with cellulose and after five washes with Tris-HCl buffer, fluorescence levels were measured in the cellulose pellet fractions (Figure 9). We observed that the fluorescence levels in the cellulose pellet incubated with Cerberus protein clicked to FITC were about 3 times higher than in the control experiments corresponding to the cellulose pellet incubated with FITC alone. These results show that Cerberus can efficiently be conjugated to fluorescent molecules bearing a DBCO group by click chemistry and that the resulting fluorescent molecules strongly interact with cellulose. Therefore, Cerberus is both a convenient and potent platform to functionalise cellulose.

Validation using paramagnetic beads

We further characterize the functionality of Cerberus in a second set of experiments using paramagnetic beads. To bind paramagnetic beads to Cerberus, we performed a click reaction using 3.2 µM of Cerberus protein and 32 µM DBCO-conjugated paramagnetic beads. As a control experiment, 32 µM of paramagnetic beads were used. These samples were then incubated with cellulose, and after five washes with Tris-HCl buffer, we measured the magnetisation of cellulose using a magnet.

Figure 5: Video of the Cerberus-functionalised paramagnetic cellulose: on the left, control with paramagnetic beads alone; on the right, Cerberus-paramagnetic beads.

As observed on the video (Figure 5), the cellulose incubated with the Cerberus protein conjugated to paramagnetic beads is quickly and totally attracted by the magnet. In contrast, in the control experiment, no clear movement towards the magnet was observed.

These results show that Cerberus has the ability to interact simultaneously with cellulose and molecules with a DBCO group, confirming that the Cerberus platform allows to functionalise cellulose through its linker containing unnatural amino acid.

Towards other functionalisations

To go further in our project, we decided to functionalise two inorganic molecules, graphene and carbon nanotubes (CNT), using a reaction of diazotization. This experiment was performed with the help of the ENSIACET laboratory in Toulouse. To check functionalisation, we analysed samples by Thermogravimetric Analysis (TGA). The concept of TGA consists of measuring the mass change of a sample depending on temperature and time, in a controlled atmosphere. We chose to perform the experiment under nitrogen, N2, an inert gas that avoids mass loss by oxidation, and we studied the mass change from 25 to 1,000 °C (15 °C/min).

Mass loss
Figure 6: Analysis of mass loss for functionalised CNT sample
Mass loss
Figure 7: Analysis of mass loss for non-functionalised CNT sample

Figures 6 and 7 present the results of mass loss for non-activated Carbon Nanotube (CNT) and activated CNT samples, respectively. For activated CNT sample (Figure 7), we observed a mass loss of 27.4% around 100 °C corresponding to water loss. A second step of mass loss is observed around 550 °C, with a diminution of 19.8%. For the non-activated sample (Figure 6), we observed two mass losses at 150 and 750 °C corresponding to 1.5% and 3% of mass loss respectively. The significative difference between these two samples allowed us to conclude that the CNT activation has been successful.

Mass loss
Figure 8: Analysis of mass loss for activated graphene sample
Mass loss
Figure 9: Analysis of mass loss for non-activated graphene sample

Figures 8 and 9 present the results of mass loss for non-activated graphene and activated graphene samples respectively. For activated graphene sample (Figure 9), we observed a mass loss of 31.0% around 100 °C corresponding to water loss. A second step of mass loss is observed around 500 °C, with a diminution of 19.0%. For the non-activated sample (Figure 8), we did not observe a significative mass loss. So we can conclude that the graphene activation has been successful.

Our initial plan was to functionalise cellulose with CNT and graphene in order to change cellulose fibre rigidity and create conductive cellulose, respectively. Unfortunately, we did not have enough time during the course of the iGEM competition to complete these tests. Given the success of the other functionalisation, we have reasonable hopes that these experiments will be successful too.

Perspectives

Our experiments provide robust proofs of concept that Cerberus can be conjugated, via its unnatural amino acid AzF, to organic or inorganic molecules bearing a DBCO group by click chemistry. The resulting molecules strongly interact with cellulose and are therefore potent cellulose functionalising compounds.

We can now consider fixation of various compounds that can be chemically functionalised. We can also imagine double fixations, for example a fluorophore on the streptavidin head and paramagnetic beads on the AzF linker. This double fixation allows us to envision endless possibilities to functionalise cellulose (see Demonstrate).

Bacterial Cellulose production and functionalisation


Background

Our ultimate dream was to be able to produce functionalised cellulose in vivo. Some microorganisms naturally produce cellulose. One of these, Gluconacetobacter hansenii, can produce cellulose as a biofilm to protect itself. We took advantage of the work of iGEM Imperial team 2014 who set up culture conditions to optimize cellulose production. Our challenge was to assess if our technology is compatible with bacterial cellulose as a first step before producing functionalised cellulose in vivo.

Key Achievements

  • Production of about 100g of dried bacterial cellulose

  • Functionalisation of bacterial cellulose with Sirius

Materials and Methods

G. hansenii was grown in Hestrin-Shramm (HS) medium at 30 °C. After one week of culture, bacterial cellulose was extracted and purified. For the experimental details, see our experiments page.

For the functionalisation, bacterial cellulose was incubated with purified Sirius (CBM3a-mRFP1) or with purified mRFP1 alone as a control. Cellulose was then washed about 10 times with Tris-HCl buffer buffer to remove non-attached proteins.

Results and Discussion

Fluorescence Retained
Figure 1: a) Picture of functionalised cellulose with Sirius (CBM3a fused with mRFP1). Left: control mRFP1 alone; Right: Sirius ;b) Picture under UV of functionalised cellulose with Sirius (CBM3a fused with mRFP1). Left: control mRFP1 alone; Right: Sirius

Figure 1a presents the results of the functionalisation of our bacterial cellulose with the Sirius fluorescent protein. Only the cellulose sample incubated with Sirius kept the color after several washes with resuspension buffer. Likewise fluorescence remained associated to cellulose only for Sirius (Figure 1b). These results show that CBM3a can interact with the bacterial cellulose and allows fixation of the mRFP1 protein to cellulose.

Perspectives

Now that we have proved the capacity of CBM3a to interact with bacterial cellulose, we are confident that Orthos and Cerberus proteins should also interact with bacterial cellulose. Now the next step will be to produce functionalised bacterial cellulose in vivo . For this, we had planned to produce the Cerberus platform in the yeast Pichia pastoris because of its secretion capacity. Indeed, our idea was to co-culture both strains in the same reactor in order to produce functionalised cellulose in vivo. This work on P. pastoris was performed at the same time as our attempt in E. coli but has not been as successful. We managed to produce the Orthos protein in the yeast but we never succeeded in producing Sirius and we never got the plasmid needed to produce the tRNA synthetase necessary for AzF incorporation in P. pastoris. In addition, the production of Orthos in the yeast was very low and not sufficient to conduct our assays. So production of functionalised cellulose in vivo will require improving the P. pastoris part of our project.